Home NDC 49502-425 SYMFI LO
Product NDC 49502-425
11-digit product format 495020425
Labeler code 49502
Product ID 49502-425_b3c95eed-7579-40b4-bf99-1530b71a975a
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Mylan Specialty L.P.
Application NDA208255
Marketing category NDA
Marketing start 2018-03-13
Marketing end 0000-00-00
Substance EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Active strength 400 mg/1; mg/1; mg/1
Pharmacologic classes Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [EXT],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 2 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Product NDC Package NDC Code Status Reporting period Archive Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product 49502-425 D Discontinued by firm excluded / ndc_excluded.zip d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 49502-425 49502-425-93 D Discontinued by firm excluded / ndc_excluded.zip d630ba8d3edf…732f749b63fb…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N208255-001 SYMFI LO EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE 400MG;300MG;300MG TABLET / ORAL RLD 2018-02-05
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 43 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL RLD 2018-02-05 84e616aacf4f…2026-08-18 06:07:40 2026-07 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL RLD 2018-02-05 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL RLD 2018-02-05 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL RLD, RS 2018-02-05 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL RLD, RS 2018-02-05 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL RLD, RS 2018-02-05 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL RLD, RS 2018-02-05 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N208255-001 SYMFI LO 400MG;300MG;300MG TABLET / ORAL AB RLD, RS 2018-02-05 f41ea6bd6efb…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 49502-425 SYMFI LO (EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [VIATRIS SPECIALTY LLC] 8 Legacy NDC 20250212_86aad85d-5460-4c38-9761-a225e6bce190.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 49502-425-93 49502042593 1 BOTTLE, PLASTIC in 1 CARTON (49502-425-93) > 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC 2018-03-13 0000-00-00 No No Current